BioCentury | Jun 9, 2020
Deals

AstraZeneca eyes August trial start for COVID-19 mAb pair

...sequences. It also partnered with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | Apr 29, 2020
Product Development

Clover becomes latest COVID-19 vaccine developer to gain CEPI funding as Moderna, Jenner continue to advance

...influenza and RSV. Sarepta, USAMRIID explore ASO therapies Sarepta Therapeutics Inc. (NASDAQ:SRPT) partnered with the U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Apr 9, 2020
Product Development

AZ’s Pangalos: what the pharma brings to COVID-19 fight, and where it turns to others

...University Medical Center, and partnering with United States Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | Feb 28, 2020
Distillery Therapeutics

Sudan ebolavirus glycoprotein-targeting mAbs to treat Sudan virus infection

...online Feb. 3, 2020 doi:10.1073/pnas.1914985117 CONTACT: John M. Dye, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md. email: john.m.dye1.civ@mail.mil Claire Quang U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...a cleavage product of CCHFV GP, could prevent and treat Crimean-Congo hemorrhagic fever virus infection U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Jul 25, 2019
Distillery Therapeutics

mAb against GP38 glycoprotein for Crimean-Congo hemorrhagic fever virus infection

...U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md. email: joseph.w.golden.ctr@mail.mil CONTACT: Aura Garrison, same affiliation as above email: aura.r.garrison.civ@mail.mil Claire Quang U.S. Army Medical Research Institute of Infectious Diseases Crimean-Congo...
BioCentury | Jul 16, 2018
Company News

Spero nabs funding for antibiotic

...the antibiotic for complicated urinary tract infections (cUTIs) caused by antibiotic-resistant Gram-negative bacteria. The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | May 25, 2018
Company News

WHO to start treatment with Merck's Ebola vaccine

...licensed two of Zmapp's mAbs from Defyrus Inc. (Toronto, Ontario), and the third mAb from U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | May 18, 2018
Politics & Policy

WHO: Congo may approve mAb Zmapp for Ebola outbreak

...licensed two of Zmapp's mAbs from Defyrus Inc. (Toronto, Ontario), and the third mAb from U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Mar 22, 2018
Emerging Company Profile

Hatching antibodies

...Medical Center and Harvard and preclinical antibodies against Ebola virus and Zika virus with the U.S. Army Medical Research Institute of Infectious Diseases...
...Stu Greenberg, Yasuhiro Tsukamoto, Koichi Kimura, Makoto Goda University collaborators: Harvard University, Massachusetts General Hospital, U.S. Army Medical Research Institute of Infectious Diseases...
...Massachusetts General Hospital, Boston, Mass. Ostrich Pharma Ltd., Kyoto, Japan OstriGen Inc., Waltham, Mass. U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID...
Items per page:
1 - 10 of 66
BioCentury | Jun 9, 2020
Deals

AstraZeneca eyes August trial start for COVID-19 mAb pair

...sequences. It also partnered with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | Apr 29, 2020
Product Development

Clover becomes latest COVID-19 vaccine developer to gain CEPI funding as Moderna, Jenner continue to advance

...influenza and RSV. Sarepta, USAMRIID explore ASO therapies Sarepta Therapeutics Inc. (NASDAQ:SRPT) partnered with the U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Apr 9, 2020
Product Development

AZ’s Pangalos: what the pharma brings to COVID-19 fight, and where it turns to others

...University Medical Center, and partnering with United States Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | Feb 28, 2020
Distillery Therapeutics

Sudan ebolavirus glycoprotein-targeting mAbs to treat Sudan virus infection

...online Feb. 3, 2020 doi:10.1073/pnas.1914985117 CONTACT: John M. Dye, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md. email: john.m.dye1.civ@mail.mil Claire Quang U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...a cleavage product of CCHFV GP, could prevent and treat Crimean-Congo hemorrhagic fever virus infection U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Jul 25, 2019
Distillery Therapeutics

mAb against GP38 glycoprotein for Crimean-Congo hemorrhagic fever virus infection

...U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md. email: joseph.w.golden.ctr@mail.mil CONTACT: Aura Garrison, same affiliation as above email: aura.r.garrison.civ@mail.mil Claire Quang U.S. Army Medical Research Institute of Infectious Diseases Crimean-Congo...
BioCentury | Jul 16, 2018
Company News

Spero nabs funding for antibiotic

...the antibiotic for complicated urinary tract infections (cUTIs) caused by antibiotic-resistant Gram-negative bacteria. The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID...
BioCentury | May 25, 2018
Company News

WHO to start treatment with Merck's Ebola vaccine

...licensed two of Zmapp's mAbs from Defyrus Inc. (Toronto, Ontario), and the third mAb from U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | May 18, 2018
Politics & Policy

WHO: Congo may approve mAb Zmapp for Ebola outbreak

...licensed two of Zmapp's mAbs from Defyrus Inc. (Toronto, Ontario), and the third mAb from U.S. Army Medical Research Institute of Infectious Diseases...
BioCentury | Mar 22, 2018
Emerging Company Profile

Hatching antibodies

...Medical Center and Harvard and preclinical antibodies against Ebola virus and Zika virus with the U.S. Army Medical Research Institute of Infectious Diseases...
...Stu Greenberg, Yasuhiro Tsukamoto, Koichi Kimura, Makoto Goda University collaborators: Harvard University, Massachusetts General Hospital, U.S. Army Medical Research Institute of Infectious Diseases...
...Massachusetts General Hospital, Boston, Mass. Ostrich Pharma Ltd., Kyoto, Japan OstriGen Inc., Waltham, Mass. U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID...
Items per page:
1 - 10 of 66